Study Design and Recruitment into the Cimzia Pregnancy Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project

被引:0
|
作者
Chambers, C. D. [1 ]
Adams, J. [2 ]
Xu, R. [1 ]
Johnson, D. L. [1 ]
Jones, K. L. [1 ]
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Univ Massachusetts, Boston, MA 02125 USA
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
P21
引用
收藏
页码:412 / 412
页数:1
相关论文
共 50 条
  • [11] Pregnancy Outcomes in Women Exposed to Adalimumab: the OTIS Autoimmune Diseases in Pregnancy Project
    Johnson, Diana L.
    Jones, Kenneth L.
    Chambers, Christina D.
    Salas, Elizabeth
    GASTROENTEROLOGY, 2009, 136 (05) : A27 - A27
  • [12] Pregnancy outcomes in women exposed to adalimunab: The OTIS autoimmune diseases in pregnancy project
    Johnson, D. L.
    Chambers, C. D.
    Jones, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 174 - 174
  • [13] Pregnancy outcomes in women exposed to adalimumab: The OTIS autoimmune diseases in pregnancy project
    Chambers, Christina
    Johnson, Diana
    Jones, Kenneth
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB10 - AB10
  • [14] Results From the Vedolizumab Pregnancy Exposure Registry: An OTIS Pregnancy Study
    Chambers, Christina D.
    Adams, Jane
    Xu, Ronghui
    Johnson, Diana
    Luo, Yunjun
    Jones, Kenneth Lyons
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S416 - S416
  • [15] Pregnancy Outcome in Women Treated with Etanercept: An Update on the OTIS Autoimmune Diseases in Pregnancy Project
    Chambers, Christina D.
    Johnson, Diana L.
    Luo, Yunjun
    Xu, Ronghui
    Jones, Kenneth L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 402 - 402
  • [16] Pregnancy outcome in women exposed to leflunomide: The OTIS autoimmune diseases in pregnancy project.
    Chambers, Christina D.
    Johnson, Diana L.
    Jones, Kenneth Lyons
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S250 - S251
  • [17] Pregnancy Outcome in Women Treated with Etanercept: An Update on the OTIS Autoimmune Diseases in Pregnancy Project
    Chambers, C. D.
    Johnson, D. L.
    Luo, Y.
    Jones, K. L.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2015, 103 (05) : 388 - 388
  • [18] Pregnancy outcome in women exposed to adalimumab: The OTIS autoimmune diseases in pregnancy project.
    Chambers, Christina D.
    Johnson, Diana L.
    Jones, Kenneth Lyons
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S251 - S251
  • [19] Recruitment Efforts and Enrollment into the OTIS Actemra Pregnancy Registry
    Chambers, C. D.
    Johnson, D. L.
    Miller, K.
    Bezchinsky, M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (05) : 366 - 366
  • [20] Pregnancy Outcome in Women Treated with Adalimumab for Rheumatoid Arthritis: An Update on the OTIS Autoimmune Diseases in Pregnancy Project
    Chambers, Christina D.
    Johnson, Diana L.
    Luo, Yunjun
    Xu, Ronghui
    Jones, Kenneth L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 399 - 399